Placebo-controlled multicentre randomised trial of interferon ß-1b in treatment of secondary progressive multiple sclerosis.

L Kappos, Study Group on Interferon β-1b in Secondary Progressive MS European, CO Hanemann

Research output: Contribution to journal › Article › peer-review

Access to Document

@article{5845df1a586d469ba8008b25c16cb3b9,

title = "Placebo-controlled multicentre randomised trial of interferon {\ss}-1b in treatment of secondary progressive multiple sclerosis.",

author = "L Kappos and European, {Study Group on Interferon β-1b in Secondary Progressive MS} and CO Hanemann",

year = "1998",

month = nov,

day = "7",

doi = "10.1016/S0140-6736(98)10039-9",

language = "English",

volume = "352",

pages = "1491--1497",

journal = "The Lancet",

issn = "0140-6736",

publisher = "Elsevier B.V.",

number = "9139",

}

TY - JOUR

T1 - Placebo-controlled multicentre randomised trial of interferon ß-1b in treatment of secondary progressive multiple sclerosis.

AU - Kappos, L

AU - European, Study Group on Interferon β-1b in Secondary Progressive MS

AU - Hanemann, CO

PY - 1998/11/7

Y1 - 1998/11/7

U2 - 10.1016/S0140-6736(98)10039-9

DO - 10.1016/S0140-6736(98)10039-9

M3 - Article

SN - 0140-6736

VL - 352

SP - 1491

EP - 1497

JO - The Lancet

JF - The Lancet

IS - 9139

ER -